Log in | Join Free | china | japan | germany
ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Tofacitinib Impurity W

Tofacitinib Impurity W

Request For Quotation
Tofacitinib Impurity W Suppliers list
Company Name: ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel: +8618627948422
Email: sale@hdimpurity.com
Products Intro: Product Name:Tofacitinib Impurity W
Purity:0.98 Package:10mg|25mg|50mg
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Tofacitinib Impurity W
Remarks:One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rh
Company Name: Nanjing XiZe Biotechnology CO., Ltd.  
Tel: 025-66023220 0086-15250997978
Email: 1511893459@qq.com
Products Intro: Product Name:Tofacitinib Impurity W
Purity:95% HPLC Package:10mg;25mg;50mg;100mg;250mg;500mg;1g
Company Name: Nanjing wangzhixing Pharmaceutical Technology Co., Ltd  
Tel: 15850510341
Email: shiqingran@wzxchem.com
Products Intro: Product Name:Tofacitinib Impurity W
Purity:99% HPLC Package:20mg 50mg 100mg
Company Name: Shenzhen Excellent Biomedical Technology Co., Ltd.  
Tel: 18318671572
Email: 2850803126@qq.com
Products Intro: Product Name:Tofacitinib Impurity W
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
Tofacitinib Impurity W Basic information
Product Name:Tofacitinib Impurity W
Synonyms:Tofacitinib Impurity W
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Tofacitinib Impurity W Structure
Tofacitinib Impurity W Chemical Properties
Safety Information
MSDS Information
Tofacitinib Impurity W Usage And Synthesis
Tofacitinib Impurity W Preparation Products And Raw materials
Tag:Tofacitinib Impurity W Related Product Information
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide (3S,4S)-Tofacitinib 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Tofacitinib Impurity X 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 6 Tofacitinib impurity V Tofacitinib Impurity 5 N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine Tofacitinib Impurity J Tofacitinib Impurity K